U.S. Water Utilities Stock News

NYSE:TAL
NYSE:TALConsumer Services

Assessing TAL Education Group (TAL) After Shares Rally And Regulatory Reset

If you are wondering whether TAL Education Group's current share price reflects its true worth, you are not alone. This article is built to help you put a number around that question. The stock last closed at US$12.70, with returns of 13.5% over 7 days, 16.4% over 30 days, 10.5% year to date, 3.8% over 1 year, 87.3% over 3 years and an 84.2% decline over 5 years. Recent news around TAL has focused on the company finding its footing within China's evolving after school tutoring rules and...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

A Look At Flywire (FLYW) Valuation After Recent Share Price Weakness

Recent performance snapshot Flywire (FLYW) has drawn investor attention after a stretch of weaker share performance, with the stock showing a 2.4% decline over the past day and a 34.8% decline over the past year. Over the past month, Flywire has recorded an 11.0% decline. The past 3 months show a 5.4% decline and the year-to-date return is a 9.4% decline, all measured against a last close of US$12.60. See our latest analysis for Flywire. For Flywire, the weak 1 year total shareholder return...
NYSE:SNDR
NYSE:SNDRTransportation

Schneider National (SNDR) Margin Compression To 1.8% Tests Bullish Earnings Growth Narrative

Schneider National (SNDR) has wrapped up FY 2025 with fourth quarter revenue of US$1.4 billion and basic EPS of US$0.13, alongside net income of US$22.1 million. This sets the tone for a year where trailing twelve month revenue reached US$5.7 billion and EPS came in at US$0.59. Over recent quarters the company has reported revenue in a range between US$1.3 billion and US$1.5 billion, with quarterly EPS moving between roughly US$0.11 and US$0.21. For investors, the key question now is how...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Is IDEAYA Biosciences (IDYA) Pricing Reflect Its DCF Upside After Recent Share Pullback

If you are wondering whether IDEAYA Biosciences is trading at a fair price or not, you are in the right place because this article focuses squarely on what you are paying versus what you are getting. Despite some recent volatility, with the share price at US$32.19 and returns of 7.5% decline over 7 days, 6.9% decline over 30 days and 4.9% decline year to date, the stock still shows a 32.2% return over 1 year, 83.3% over 3 years and 67.2% over 5 years. Recent company specific developments and...
NYSE:GME
NYSE:GMESpecialty Retail

GameStop Targets Larger Consumer Deal As Cohen Pursues Conglomerate Future

GameStop (NYSE:GME) has announced plans to acquire a much larger publicly traded consumer company as part of a pivot toward a diversified conglomerate model. CEO Ryan Cohen is leading the effort, backed by a new performance-based pay plan and support from high-profile investors, including Michael Burry. The company cites its liquidity position as a key resource for pursuing this transformational deal, which would significantly expand GameStop's scale and industry reach. For investors, this...
NYSE:USB
NYSE:USBBanks

How Earnings Growth, Buybacks and New Debt Issuance Will Impact U.S. Bancorp (USB) Investors

U.S. Bancorp recently reported higher fourth-quarter and full-year 2025 earnings, continued share repurchases under its existing buyback program, and issued a series of new senior notes spanning 2032 to 2046 with both fixed and variable coupons. The bank is also undergoing a planned leadership transition, with CEO and President Gunjan Kedia set to become chair in April 2026 and longtime executive Souheil Badran retiring after helping embed automation and artificial intelligence across...
NYSE:CL
NYSE:CLHousehold Products

Colgate-Palmolive’s 2030 Plan Weighs Latin America Rebound And Pet Nutrition

Colgate-Palmolive (NYSE:CL) has set out a 2030 company plan focused on brands, product development, digital tools and supply chain efficiency. The plan comes alongside a turnaround in Latin America following earlier product issues in the region. The company is putting extra weight behind Hill’s pet nutrition and recent acquisitions, while its skin health unit faces weaker conditions, particularly in China. For investors watching consumer staples, Colgate-Palmolive sits in the spotlight with...
NYSE:KMX
NYSE:KMXSpecialty Retail

Should Giverny Capital’s Exit Over Omnichannel Payoff Concerns Require Action From CarMax (KMX) Investors?

Giverny Capital Asset Management disclosed in its fourth-quarter 2025 investor letter that it had fully exited its long-term holding in CarMax, criticizing management for not adjusting effectively to a tougher used car market marked by expensive vehicles, higher financing costs, and limited supply of 2–5 year-old cars. The move underscores how even long-term institutional holders can lose confidence when a retailer’s costly investments, such as CarMax’s omnichannel platform, fail to...
NYSE:LVS
NYSE:LVSHospitality

Is Las Vegas Sands (LVS) Pricing Looked At Again After Recent Share Price Slide?

If you are wondering whether Las Vegas Sands is attractively priced or not, starting with a clear view of its current valuation can help you decide how it might fit into your portfolio. The stock closed at US$52.73, with a 12% decline over the past 7 days and a 19% decline over the past 30 days, while the 1 year return sits at 17.5% and the 3 year and 5 year returns are 4.9% and 0.6% declines respectively. Recent coverage has focused on Las Vegas Sands as a large US listed casino and resort...
NYSE:TRV
NYSE:TRVInsurance

How Investors May Respond To Travelers (TRV) Earnings Beat, Higher Dividend And Larger Buyback Authorization

The Travelers Companies, Inc. reported full-year 2025 revenue of US$48.83 billion and net income of US$6.29 billion, while affirming a US$1.10 quarterly dividend and expanding its share repurchase authorization by US$5.00 billion. Together with its earnings release, Travelers’ decision to increase its long-running buyback program underscores management’s focus on sustained capital returns to shareholders. Next, we’ll examine how Travelers’ combination of earnings growth and an expanded...
NYSE:TGNA
NYSE:TGNAMedia

Will TEGNA's (TGNA) Mobile App Push and Award-Winning Journalism Deepen Its Local-Media Moat?

TEGNA Inc. recently rolled out new personalized local news and weather apps across 50 markets and saw audience engagement climb, while its Atlanta NBC affiliate WXIA (11Alive) won the 2026 Alfred I. duPont-Columbia University Award for the “Help That Harms” investigation that drove statewide policy reforms in Georgia. Together, the surge in mobile usage and high-profile recognition for impactful journalism underscore TEGNA’s strengthening connection with local audiences and public...
NYSE:SPHR
NYSE:SPHREntertainment

Sphere Entertainment Tests Smaller Sphere Model With Maryland National Harbor Plan

Sphere Entertainment (NYSE:SPHR) announced plans for a new venue at National Harbor in Maryland, its second U.S. location. The project will use a smaller scale design compared with the company’s existing U.S. venue. The development is expected to bring Sphere’s immersive entertainment concept to the Washington, D.C. metropolitan area. Company communications highlight anticipated economic, cultural, and community impacts, including job creation and public private investment. Sphere...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Exit From Offshore Wind Recasts Focus On Regulated Earnings

Eversource Energy (NYSE:ES) is exiting its offshore wind partnership with Orsted. The company plans to refocus on its core regulated utility operations following this exit. This change affects how Eversource allocates capital between renewables projects and regulated businesses. Eversource Energy runs regulated electric, gas, and water utilities, which typically follow defined rate frameworks set by regulators. Stepping away from the offshore wind joint venture signals a preference for...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Is Fox (FOXA) Still Attractive After A 43.5% One Year Share Price Jump

If you are wondering whether Fox shares still offer value after recent gains, this article will walk through what the current price could be implying about the company. Fox closed at US$72.78, with returns of 43.5% over 1 year and 147.2% over 5 years. This is the case even though the stock is roughly flat over the last month and year to date. Recent price moves sit against a backdrop of ongoing interest in US media groups and how they position themselves across traditional TV and digital...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is Nasdaq (NDAQ) Pricing Look Justified After Strong Multi Year Share Gains?

If you are asking whether Nasdaq stock looks reasonably priced or stretched right now, you are in the right place for a clear, valuation focused look at the numbers. The share price closed at US$96.89 recently, with returns of 19.1% over 1 year, 67.0% over 3 years and 118.2% over 5 years. Shorter term moves of a 1.2% decline over 7 days and a 0.2% decline over 30 days show a more muted picture. Recent coverage has focused on Nasdaq's role in capital markets infrastructure and ongoing...
NYSE:CNH
NYSE:CNHMachinery

CNH Industrial’s R4 Robot Extends Automation Push Into Specialty Crop Services

CNH Industrial (NYSE:CNH) has introduced its R4 autonomous robot, aimed at addressing labor shortages in specialty crop farming. The launch focuses on automated solutions for tasks in high value crops where finding and retaining workers can be difficult. This move builds on CNH Industrial's broader push into automation and robotics within agriculture equipment. For you as an investor, the R4 robot sits at the intersection of machinery, software, and farm operations, an area that has been...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Is Tilray Brands' (TLRY) Italian Medical Push Quietly Redefining Its Global Cannabis Strategy?

Earlier in January 2026, Tilray Medical, a division of Tilray Brands, expanded its European medical cannabis operations by launching Tilray Medical Italia, rebranding the former FL Group and broadening an Italian Ministry of Health–authorized product portfolio in partnership with Molteni Farmaceutici. This move not only deepens Tilray’s presence in one of Europe’s most tightly regulated medical cannabis markets, it also advances its goal of building a unified global medical cannabis platform...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Is Travere Therapeutics (TVTX) Offering Value After Recent Share Price Swings?

If you are wondering whether Travere Therapeutics at around US$31.09 is offering fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock has had a mixed run, with a 5.6% gain over the last 7 days but an 18.6% decline over 30 days, while still sitting on a 52.0% return over 1 year and 43.1% over 3 years, compared with a 2.1% decline over 5 years. Recent coverage of Travere Therapeutics has focused on its position in the...
NYSE:ANF
NYSE:ANFSpecialty Retail

A Look At Abercrombie & Fitch (ANF) Valuation After Its New NFL Super Bowl Fashion Partnership

Abercrombie & Fitch (ANF) is back in focus after being named the NFL's Official Fashion Partner for the upcoming Super Bowl, tying its stock story to high visibility events across sports and fashion. See our latest analysis for Abercrombie & Fitch. The Super Bowl tie up comes at a time when Abercrombie & Fitch’s share price of $97.63 sits below recent highs. A 90 day share price return of 34.57% contrasts with a 22.44% decline over 30 days and a three year total shareholder return of 224.68%,...
NYSE:LUV
NYSE:LUVAirlines

Is It Too Late To Consider Southwest Airlines (LUV) After Its Strong Share Price Run?

If you are wondering whether Southwest Airlines is still fairly priced after its recent run, you are not alone. This article focuses squarely on what the current share price might be implying. The stock recently closed at US$47.52, with returns of 13.3% over 7 days, 15.0% over 30 days, 15.1% year to date, 58.1% over 1 year and 39.8% over 3 years, while the 5 year return stands at 2.0%. Recent headlines around Southwest Airlines have focused on its operational recovery and route capacity...
NYSE:GENI
NYSE:GENIHospitality

Reassessing Genius Sports (GENI) After Recent Share Price Weakness And DCF Upside Potential

If you are wondering whether Genius Sports is offering fair value at its current price, you are not alone, as the stock has been attracting attention from investors who want to know what they are really paying for its growth story. The shares last closed at US$8.70, with returns of a 10% decline over 7 days, a 21.1% decline over 30 days, a 19.3% decline year to date and a 1.5% decline over 1 year, while the 3 year return sits at 59.3% and the 5 year return at a 58.1% decline. Recent news...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

ARK’s Bigger CRISPR Therapeutics Stake Underscores Gene Editing Pipeline Story

ARK Investment Management has significantly expanded its position in CRISPR Therapeutics (NasdaqGM:CRSP), purchasing a large block of shares. The move highlights ARK's confidence in CRISPR Therapeutics' role in gene editing and its clinical pipeline. The news coincides with continued work on gene editing therapies targeting beta thalassemia, sickle cell disease, cardiovascular conditions, and type 1 diabetes. CRISPR Therapeutics' share price recently stood at $49.96, with the stock showing...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

East West Bancorp (EWBC) Valuation After Earnings Beat And 33% Dividend Increase

East West Bancorp (EWBC) just reported stronger than expected fourth quarter results and announced a 33% increase in its quarterly dividend to $0.80 per share, a combination that sharpened the market’s focus on the stock. See our latest analysis for East West Bancorp. The latest set of results and the higher dividend come after a strong run for the stock, with a 90 day share price return of 12.64% and a 1 year total shareholder return of 13.93%. The 5 year total shareholder return of 100.36%...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Is Cirrus Logic (CRUS) Pricing Make Sense After Strong Multi‑Year Share Price Gains

If you are wondering whether Cirrus Logic shares still offer value at current levels, this article walks through what the numbers are really saying about the stock. The share price last closed at US$130.34, with returns of 2.4% over 7 days, 10.0% over 30 days, 8.9% year to date, 29.8% over 1 year and 52.7% over 5 years, which may have caught the attention of investors who follow price trends closely. Recent coverage around Cirrus Logic has focused on its role in the semiconductor space and...